BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 22398102)

  • 41. Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation.
    Alexander J; Lord JD; Yeh MM; Cuevas C; Bakthavatsalam R; Kowdley KV
    Liver Transpl; 2008 Feb; 14(2):245-51. PubMed ID: 18236405
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Activity of Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis Predicts Poorer Clinical Outcomes.
    Peverelle M; Paleri S; Hughes J; De Cruz P; Gow PJ
    Inflamm Bowel Dis; 2020 Nov; 26(12):1901-1908. PubMed ID: 31944235
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enhanced liver fibrosis test predicts transplant-free survival in primary sclerosing cholangitis, a multi-centre study.
    de Vries EMG; Färkkilä M; Milkiewicz P; Hov JR; Eksteen B; Thorburn D; Chazouillères O; Pares A; Nygård S; Gilja OH; Wunsch E; Invernizzi P; Carbone M; Bernuzzi F; Boberg KM; Røsjø H; Rosenberg W; Beuers UH; Ponsioen CY; Karlsen TH; Vesterhus M
    Liver Int; 2017 Oct; 37(10):1554-1561. PubMed ID: 28267887
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical course and management of inflammatory bowel disease after liver transplantation.
    Befeler AS; Lissoos TW; Schiano TD; Conjeevaram H; Dasgupta KA; Millis JM; Newell KA; Thistlethwaite JR; Baker AL
    Transplantation; 1998 Feb; 65(3):393-6. PubMed ID: 9484758
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Validation of the prognostic value of histologic scoring systems in primary sclerosing cholangitis: An international cohort study.
    de Vries EM; de Krijger M; Färkkilä M; Arola J; Schirmacher P; Gotthardt D; Goeppert B; Trivedi PJ; Hirschfield GM; Ytting H; Vainer B; Buuren HR; Biermann K; Harms MH; Chazouilleres O; Wendum D; Kemgang AD; Chapman RW; Wang LM; Williamson KD; Gouw AS; Paradis V; Sempoux C; Beuers U; Hübscher SG; Verheij J; Ponsioen CY
    Hepatology; 2017 Mar; 65(3):907-919. PubMed ID: 27880989
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Temporal trends in colon neoplasms in patients with primary sclerosing cholangitis and ulcerative colitis.
    Navaneethan U; Venkatesh PG; Lashner BA; Remzi FH; Shen B; Kiran RP
    J Crohns Colitis; 2012 Sep; 6(8):845-51. PubMed ID: 22398080
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Surgical outcome in patients with primary sclerosing cholangitis undergoing ileal pouch-anal anastomosis: a case-control study.
    Gorgun E; Remzi FH; Manilich E; Preen M; Shen B; Fazio VW
    Surgery; 2005 Oct; 138(4):631-7; discussion 637-9. PubMed ID: 16269291
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Unique Inflammatory Bowel Disease Phenotype of Pediatric Primary Sclerosing Cholangitis: A Single-Center Study.
    Shiau H; Ihekweazu FD; Amin M; Fofanova T; Miloh T; Kellermayer R
    J Pediatr Gastroenterol Nutr; 2017 Oct; 65(4):404-409. PubMed ID: 28141677
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Colectomy for patients with ulcerative colitis and primary sclerosing cholangitis - what next?
    Block M; Jørgensen KK; Oresland T; Lindholm E; Grzyb K; Cvancarova M; Vatn MH; Boberg KM; Börjesson L
    J Crohns Colitis; 2014 May; 8(5):421-30. PubMed ID: 24239402
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Duration of Inflammatory Bowel Disease Is Associated With Increased Risk of Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis and IBD.
    Gulamhusein AF; Eaton JE; Tabibian JH; Atkinson EJ; Juran BD; Lazaridis KN
    Am J Gastroenterol; 2016 May; 111(5):705-11. PubMed ID: 27002801
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inflammatory bowel disease complicated by primary sclerosing cholangitis and cirrhosis: is restorative proctocolectomy safe?
    Lian L; Menon KV; Shen B; Remzi F; Kiran RP
    Dis Colon Rectum; 2012 Jan; 55(1):79-84. PubMed ID: 22156871
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The combination of primary sclerosing cholangitis and CCR5-Δ32 in recipients is strongly associated with the development of nonanastomotic biliary strictures after liver transplantation.
    op den Dries S; Buis CI; Adelmeijer J; Van der Jagt EJ; Haagsma EB; Lisman T; Porte RJ
    Liver Int; 2011 Sep; 31(8):1102-9. PubMed ID: 21134114
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hepatocellular carcinoma complicating primary sclerosing cholangitis in Crohn's disease. A case report.
    Demarchi B; Bresso F; Novero D; Palestro G; Sapone N; Pellicano R; Bonardi R; Smedile A; Rizzetto M; Astegiano M
    Minerva Gastroenterol Dietol; 2007 Sep; 53(3):279-83. PubMed ID: 17912190
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cholangiocarcinoma in young individuals with and without primary sclerosing cholangitis.
    Björnsson E; Angulo P
    Am J Gastroenterol; 2007 Aug; 102(8):1677-82. PubMed ID: 17433022
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Matrix metalloproteinase 2 genotype is associated with nonanastomotic biliary strictures after orthotopic liver transplantation.
    Ten Hove WR; Korkmaz KS; op den Dries S; de Rooij BJ; van Hoek B; Porte RJ; van der Reijden JJ; Coenraad MJ; Dubbeld J; Hommes DW; Verspaget HW
    Liver Int; 2011 Sep; 31(8):1110-7. PubMed ID: 21745270
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatobiliary dysfunction and primary sclerosing cholangitis in patients with Crohn's disease.
    Rasmussen HH; Fallingborg JF; Mortensen PB; Vyberg M; Tage-Jensen U; Rasmussen SN
    Scand J Gastroenterol; 1997 Jun; 32(6):604-10. PubMed ID: 9200295
    [TBL] [Abstract][Full Text] [Related]  

  • 57. No negative impact of serum IgG4 levels on clinical outcome in 435 patients with primary sclerosing cholangitis from Japan.
    Tanaka A; Tazuma S; Nakazawa T; Isayama H; Tsuyuguchi T; Inui K; Takikawa H
    J Hepatobiliary Pancreat Sci; 2017 Apr; 24(4):217-225. PubMed ID: 28103424
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fistulizing pattern in Crohn's disease and pancolitis in ulcerative colitis are independent risk factors for cancer: a single-center cohort study.
    Biancone L; Zuzzi S; Ranieri M; Petruzziello C; Calabrese E; Onali S; Ascolani M; Zorzi F; Condino G; Iacobelli S; Pallone F
    J Crohns Colitis; 2012 Jun; 6(5):578-87. PubMed ID: 22398047
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A novel prognostic model for transplant-free survival in primary sclerosing cholangitis.
    de Vries EM; Wang J; Williamson KD; Leeflang MM; Boonstra K; Weersma RK; Beuers U; Chapman RW; Geskus RB; Ponsioen CY
    Gut; 2018 Oct; 67(10):1864-1869. PubMed ID: 28739581
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical course of ulcerative colitis in patients with and without primary sclerosing cholangitis.
    Moayyeri A; Daryani NE; Bahrami H; Haghpanah B; Nayyer-Habibi A; Sadatsafavi M
    J Gastroenterol Hepatol; 2005 Mar; 20(3):366-70. PubMed ID: 15740478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.